WCMNY
ARNA

Westchester Capital Management (New York)’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Westchester Capital Management (New York)’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-224,444
Closed -$20.9M – 466
2021
Q4 		$20.9M Buy
+224,444
New +$14.8M 0.59% 21

Westchester Capital Management (New York)'s ARNA Position: Q1 2022 in Review

Westchester Capital Management (New York) sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 224,444 shares — an estimated $20.9M sold.

Westchester Capital Management (New York) first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $20.9M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Westchester Capital Management (New York) reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 224,444 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $20.9M.
  • Westchester Capital Management (New York) first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • Westchester Capital Management (New York)'s Arena Pharmaceuticals Inc position peaked at $20.9M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2022, filed 16 May 2022.